Digital Pregnancy Test Kit Market

Market Insights on the Digital Pregnancy Test Kit Market, including sales forecast, demand outlook, and key trends

Digital Pregnancy Test Kit Market– By Product Type, Distribution Channel, End User & Region - Forecast to 2023-2033

Category: Life Sciences Published Date : Jun-23 ID: CVC-45359 Format: PDF Pages: 300

Report Highlights According to a research survey conducted by ChemView Consulting, the Digital Pregnancy Test Kit Market was worth US$ 1.8 Bn. The market is expected to grow at a CAGR of 5.08% between the 2023 to 2033 to reach US$ 2.9 Bn.



Report Includes

Research Scope/Taxonomy:

  • Market Analysis by Product Type:
    • Digital Pregnancy Test Strips
    • Digital Pregnancy Test Cards
    • Digital Pregnancy Test Pens
    • Digital Pregnancy Test Midstreams
    • Digital Pregnancy Test Cups
  • Market Analysis by Distribution Channel:
    • Online Pharmacies
    • Retail Pharmacies
    • Supermarkets and Hypermarkets
    • Drugstores
    • Others
  • Market Analysis by End User:
    • Hospitals
    • Clinics
    • Home Care Settings
    • Others
  • Market Analysis by Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa







Analyst Credentials

Key Companies Profiled:

  • Procter & Gamble Co.
  • Clearblue (Hologic, Inc.)
  • First Response (Church & Dwight Co., Inc.)
  • Abbott Laboratories
  • Swiss Precision Diagnostics GmbH
  • Church & Dwight Co., Inc.
  • Confirm Biosciences
  • Quidel Corporation
  • Geratherm Medical AG
  • Prima Pharmaceuticals
  • Gregory Pharmaceutical Holdings, Inc.
  • Insight Pharmaceuticals, LLC
  • Wondfo Biotech Co., Ltd.
  • Atlas Medical-Professional Diagnostics
  • True Diagnostics, Inc.
  • Biomerieux SA
  • BTNX Inc.
  • Swiss Precision Diagnostics GmbH
  • Bio-AMD, Inc.
  • Beckman Coulter, Inc.

1.1. Global Market Snapshot

1.2. Key Success Factors

1.3. Strategic Analysis and Recommendations

2.1. Market Taxonomy

2.2. Market Definitions

3.1. Preliminary Investigation & Research Design

3.2. Secondary Research & Primary Research

3.3. Data Analysis & Econometric Modelling

3.4. Expert Data Validation

4.1. Supply-Side Trends

4.2. Demand-Side Trends

5.1. Global Market Value (US$ Mn) Analysis, 2018 – 2033

5.2. Incremental $ Opportunity Index, 2023-2033

5.3. Global Market Volume Analysis, 2018 – 2033

6.1. Regional Level Pricing Analysis and Forecast

6.1.1. Manufacturers Level Pricing

6.1.2. Distributor Level Pricing

6.2. Global Pricing Analysis Benchmark

6.3. Cost Breakdown Analysis

7.1. Cross Analysis of Distribution Channel W.R.T. Product Type

8.1. Regional Supply Vs. Demand Gap Assessment

8.2. Top Producing Countries Analysis

9.1. Macroeconomic Factors

9.2. Forecast Factors

9.3. Market Dynamics

9.3.1. Driver

9.3.2. Restraint

9.3.3. Opportunity

9.4. Supply Chain Analysis

9.4.1. List Raw Material Suppliers

9.4.2. List of Manufacturers

9.4.3. List of Distributors

9.4.4. List of End-Users

9.4.5. End-Users Consumption Analysis

9.4.6. Average Profitability Margin Analysis

9.5. Covid-19 Impact Assessment

9.5.1. Economy/Cluster Projections

9.5.2. Covid-19 Economic Assessment

9.5.3. Impact on Target Market

9.5.4. Recovery Scenario

9.6. Regulatory Framework

9.6.1. Regulations of Key Countries

9.6.2. Potential Impact of Regulations

9.7. Porter’s Five Forces Analysis

9.8. Technology Landscape

10.1. Introduction

10.2. Key Market Trends

10.3. Historical and Current Market (2018-2022) and Future Market Analysis (2023-2033) By Product Type [Value (US$ Mn) and Volume Analysis]

10.3.1. Digital Pregnancy Test Strips

10.3.2. Digital Pregnancy Test Cards

10.3.3. Digital Pregnancy Test Pens

10.3.4. Digital Pregnancy Test Midstreams

10.3.5. Digital Pregnancy Test Cups

10.4. Market Attractiveness Analysis by Product Type

11.1. Introduction

11.2. Historical and Current Market (2018-2022) and Future Market Analysis (2023-2033) By Distribution Channel [Value (US$ Mn) and Volume Analysis]

11.2.1. Online Pharmacies

11.2.2. Retail Pharmacies

11.2.3. Supermarkets and Hypermarkets

11.2.4. Drugstores

11.2.5. Others O

11.3. Market Attractiveness Analysis by Distribution Channel

12.1. Introduction

12.2. Historical and Current Market (2018-2022) and Future Market Analysis (2023-2033) By End-User [Value (US$ Mn) and Volume Analysis]

12.2.1. Hospitals

12.2.2. Clinics

12.2.3. Home Care Settings

12.2.4. Others

12.3. Market Attractiveness Analysis by End-User

13.1. Introduction

13.2. Key Market Trends

13.3. Historical and Current Market (2018-2022) and Future Market Analysis (2023-2033) By Region [Value (US$ Mn) and Volume Analysis]

13.3.1. North America

13.3.2. Latin America

13.3.3. Europe

13.3.4. Asia-Pacific

13.3.5. Middle East

13.3.6. Africa

13.4. Market Attractiveness Analysis by Region

14.1. Introduction

14.2. Key Market Trends

14.3. Historical and Current Market Size (2018-2022) and Future Market Size Analysis (2023-2033) [Value (US$ Mn) and Volume Analysis]

14.3.1. By Country

14.3.1.1. U.S.

14.3.1.2. Canada

14.3.2. By Product Type

14.3.3. By Distribution Channel

14.3.4. By End-User

14.4. Market Attractiveness Analysis

14.4.1. By Country

14.4.2. By Product Type

14.4.3. By Distribution Channel

14.4.4. By End-User

15.1. Introduction

15.2. Key Market Trends

15.3. Historical and Current Market Size (2018-2022) and Future Market Size Analysis (2023-2033) [Value (US$ Mn) and Volume Analysis]

15.3.1. By Country

15.3.1.1. Brazil

15.3.1.2. Mexico

15.3.1.3. Rest of Latin America

15.3.2. By Product Type

15.3.3. By Distribution Channel

15.3.4. By End-User

15.4. Market Attractiveness Analysis

15.4.1. By Country

15.4.2. By Product Type

15.4.3. By Distribution Channel

15.4.4. By End-User

16.1. Introduction

16.2. Key Market Trends

16.3. Historical and Current Market Size (2018-2022) and Future Market Size Analysis (2023-2033) [Value (US$ Mn) and Volume Analysis]

16.3.1. By Country

16.3.1.1. Germany

16.3.1.2. Italy

16.3.1.3. France

16.3.1.4. UK

16.3.1.5. Spain

16.3.1.6. Netherlands

16.3.1.7. Norway

16.3.1.8. Russia

16.3.1.9. Rest of Europe

16.3.2. By Product Type

16.3.3. By Distribution Channel

16.3.4. By End-User

16.4. Market Attractiveness Analysis

16.4.1. By Country

16.4.2. By Product Type

16.4.3. By Distribution Channel

16.4.4. By End-User

17.1. Introduction

17.2. Key Market Trends

17.3. Historical and Current Market Size (2018-2022) and Future Market Size Analysis (2023-2033) [Value (US$ Mn) and Volume Analysis]

17.3.1. By Country

17.3.1.1. China

17.3.1.2. Japan

17.3.1.3. South Korea

17.3.1.4. India

17.3.1.5. Indonesia

17.3.1.6. Thailand

17.3.1.7. Vietnam

17.3.1.8. Australia & New Zealand

17.3.1.9. Rest of Asia-Pacific

17.3.2. By Product Type

17.3.3. By Distribution Channel

17.3.4. By End-User

17.4. Market Attractiveness Analysis

17.4.1. By Country

17.4.2. By Product Type

17.4.3. By Distribution Channel

17.4.4. By End-User

18.1. Introduction

18.2. Key Market Trends

18.3. Pricing Analysis

18.4. Historical and Current Market Size (2018-2022) and Future Market Size Analysis (2023-2033) [Value (US$ Mn) and Volume Analysis]

18.4.1. By Country

18.4.1.1. Saudi Arabia

18.4.1.2. Turkey

18.4.1.3. U.A.E.

18.4.1.4. Rest of the Middle East

18.4.2. By Product Type

18.4.3. By Distribution Channel

18.4.4. By End-User

18.5. Market Attractiveness Analysis

18.5.1. By Country

18.5.2. By Product Type

18.5.3. By Distribution Channel

18.5.4. By End-User

19.1. Introduction

19.2. Key Market Trends

19.3. Pricing Analysis

19.4. Historical and Current Market Size (2018-2022) and Future Market Size Analysis (2023-2033) [Value (US$ Mn) and Volume Analysis]

19.4.1. By Country

19.4.1.1. South Africa

19.4.1.2. Nigeria

19.4.1.3. Egypt

19.4.1.4. Rest of Africa

19.4.2. By Product Type

19.4.3. By Distribution Channel

19.4.4. By End-User

19.5. Market Attractiveness Analysis

19.5.1. By Country

19.5.2. By Product Type

19.5.3. By Distribution Channel

19.5.4. By End-User

20.1. Tier Structure Breakdown

20.2. Market Share Analysis

20.3. Production Capacity Analysis

20.4. Company Footprint Analysis

20.4.1. Product Footprint of Players

20.4.2. Regional Footprint of Players

20.4.3. Channel Footprint of Players

20.5. Brand Preference Analysis

20.6. Competition Dashboard

21.1. Procter & Gamble Co.

21.1.1. Company Overview

21.1.2. Product & Financial Portfolio

21.1.3. Manufacturing Facilities

21.1.4. Recent Developments

21.1.5. SWOT Analysis

21.1.6. Strategy Overview

21.2. Clearblue (Hologic, Inc.)

21.3. First Response (Church & Dwight Co., Inc.)

21.4. Abbott Laboratories

21.5. Swiss Precision Diagnostics GmbH

21.6. Church & Dwight Co., Inc.

21.7. Confirm Biosciences

21.8. Quidel Corporation

21.9. Geratherm Medical AG

21.10. Prima Pharmaceuticals

21.11. Gregory Pharmaceutical Holdings, Inc.

21.12. Insight Pharmaceuticals, LLC

21.13. Wondfo Biotech Co., Ltd.

21.14. Atlas Medical-Professional Diagnostics

21.15. True Diagnostics, Inc.

21.16. Biomerieux SA

21.17. BTNX Inc.

21.18. Swiss Precision Diagnostics GmbH

21.19. Bio-AMD, Inc.

21.20. Beckman Coulter, Inc.